Two new cytotoxic phenylallylflavanones from Mexican propolis

Area of Science:

• Natural Products Chemistry
• Medicinal Chemistry
• Cancer Biology

Background:

• Propolis, a resinous mixture produced by honeybees, is known for its diverse chemical composition and biological activities.
• Flavonoids are a major class of plant secondary metabolites with a wide range of pharmacological properties, including anticancer effects.
• Pancreatic cancer remains a significant health challenge with limited effective treatment options.

Purpose of the Study:

• To isolate and characterize new phenylallylflavanone compounds from Mexican propolis.
• To evaluate the cytotoxic activity of these novel compounds against human pancreatic cancer cells (PANC-1).
• To investigate the selective toxicity of the compounds in nutrient-deprived conditions.

Main Methods:

• Extraction of bioactive compounds from a methanolic extract of Mexican propolis.
• Structure elucidation of isolated compounds using comprehensive spectroscopic analysis (e.g., NMR, Mass Spectrometry).
• In vitro cytotoxic assays to determine the half-maximal inhibitory concentration (IC50) against PANC-1 cells under nutrient-deprived conditions.

Main Results:

• Isolation and identification of two new phenylallylflavanones: (2R,3R)-6-[1-(4'-hydroxy-3'-methoxyphenyl)prop-2-en-1-yl]pinobanksin (1) and its 3-acetate derivative (2).
• Both compounds demonstrated preferential cytotoxic activity against PANC-1 cells in a nutrient-deprived medium.
• Compound 2 exhibited a lower PC50 value (9.1 μM) compared to compound 1 (17.9 μM), indicating higher potency.

Conclusions:

• The novel phenylallylflavanones isolated from Mexican propolis possess significant cytotoxic potential against pancreatic cancer cells.
• These compounds display selective activity under nutrient-deprived conditions, a characteristic relevant to the tumor microenvironment.
• Further research into these compounds may lead to the development of novel therapeutic agents for pancreatic cancer.